Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03320603 | Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants | ||
| NCT02740335 | Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk. | ||
| NCT04502030 | Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study) | ||
| NCT02256917 | Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A | ||
| NCT04376762 | Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients | ||
| NCT02115503 | A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients | ||
| NCT01938378 | Octaplas Pediatric Plasma Exchange Trial | ||
| NCT04052698 | Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD | ||
| NCT02954575 | Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A | ||
| NCT03656640 | Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases | ||
| NCT04046848 | Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A | ||
| NCT01888484 | Study of Octanorm Subcutaneous IG in Patients With PID | ||
| NCT00426270 | Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults | ||
| NCT01063595 | A Trial to Investigate the Relative Efficacy, Safety, and Tolerability of Octaplas LG Versus Octaplas SD | ||
| NCT02037373 | Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation | ||
| NCT04867837 | Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor | ||
| NCT03988426 | Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases | ||
| NCT04023019 | Treatment of Hemophilia A Patients With FVIII Inhibitors | ||
| NCT03866798 | Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP) | ||
| NCT04953884 | Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age | ||
| NCT02267226 | Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery | ||
| NCT01863758 | Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A | ||
| NCT00411801 | Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) | ||
| NCT00545493 | Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis | ||
| NCT01365546 | Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery | ||
| NCT03369301 | The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency | ||
| NCT02875236 | Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81) | ||
| NCT04053699 | Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment | ||
| NCT07220915 | Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections | ||
| NCT01992549 | Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII | ||
| NCT02253082 | Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28) | ||
| NCT02408484 | Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency | ||
| NCT02962765 | Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ | ||
| NCT04929236 | Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients | ||
| NCT02638207 | Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy | ||
| NCT02278575 | Atenativ Effect on Uterine Blood Flow and Preeclampsia | ||
| NCT04534751 | Factor In the Initial Resuscitation of Severe Trauma 2 Patients | ||
| NCT06096116 | Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass | ||
| NCT04146376 | Von Willebrand Factor in Pregnancy (VIP) Study | ||
| NCT05523297 | Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery | ||
| NCT00989196 | Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A | ||
| NCT03385395 | Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency | ||
| NCT03907241 | CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL | ||
| NCT04651400 | Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection | ||
| NCT01225276 | Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP | ||
| NCT03369314 | Observational Study of the Use of octaplasLG®. | ||
| NCT03939533 | Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases | ||
| NCT03092245 | Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial | ||
| NCT00811174 | Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases | ||
| NCT01859754 | Octagam 5% Versus Comparator Post Marketing Trial |
